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Megakaryocyte morphogenesis employs a ‘‘hyper-
trophy-like’’ developmental program that is depen-
dent on P-TEFb kinase activation and cytoskeletal
remodeling. P-TEFb activation classically occurs by
a feedback-regulated process of signal-induced,
reversible release of active Cdk9-cyclin T modules
from large, inactive 7SK small nuclear ribonucleopro-
tein particle (snRNP) complexes. Here, we have iden-
tified an alternative pathway of irreversible P-TEFb
activation in megakaryopoiesis that is mediated
by dissolution of the 7SK snRNP complex. In this
pathway, calpain 2 cleavage of the core 7SK snRNP
component MePCE promoted P-TEFb release and
consequent upregulation of a cohort of cytoskeleton
remodeling factors, including a-actinin-1. In a subset
of human megakaryocytic leukemias, the transcrip-
tion factor GATA1 undergoes truncating mutation
(GATA1s). Here, we linked the GATA1s mutation to
defects in megakaryocytic upregulation of calpain 2
and of P-TEFb-dependent cytoskeletal remodeling
factors. Restoring calpain 2 expression in GATA1s
mutant megakaryocytes rescued normal develop-
ment, implicating this morphogenetic pathway as a
target in human leukemogenesis.
INTRODUCTION
Mammalian hematopoietic differentiation proceeds by a series
of binary decisions that yield progenitors of increasingly limited
developmental potential, with the megakaryocyte lineage
emerging from a bipotent megakaryocyte-erythroid progenitor
(MEP). Megakaryocytic and erythroid cells, despite common
origins, shared transcription factors, and shared signaling
pathways, differ profoundly in their developmental programs.
Erythroid morphogenesis occurs through progressive reductionDevelopmein cell size accompanied by nuclear condensation and ultimately
extrusion. Megakaryocytic morphogenesis contrastingly in-
volvesmarked expansion in cell mass combined with acquisition
of a lobulated, polyploid nucleus containing up to 32-64N. In this
regard, megakaryopoiesis bears resemblance to the program of
cardiomyocyte hypertrophy, in which pressure overload elicits
cellular enlargement and polyploidization (Liu et al., 2010).
Mechanistically, the developmental morphogenesis of mega-
karyocytes and the hypertrophic response of cardiomyocytes
share key regulatory elements. At the transcriptional level, both
programs rely on a complex of serum response factor (SRF)
with myocardin-related transcription factors (Cheng et al.,
2009; Halene et al., 2010; Kuwahara et al., 2010; Nelson et al.,
2005; Smith et al., 2012), as well as on MEF2C (Gekas
et al., 2009; Mun˜oz et al., 2009). At the signaling level, both pro-
grams require high-amplitude activation of the P-TEFb kinase
pathway (Elagib et al., 2008; Sano et al., 2002). A critical distinc-
tion is that cardiomyocyte hypertrophy consists of a reversible
response to a pathologic stimulus, whereas normal megakaryo-
cyte morphogenesis represents an irreversible, terminal pro-
gram largely driven by cell-intrinsic mechanisms.
Cellular P-TEFb kinase activity is tightly regulated, with the
majority of the Cdk9-cyclin T kinase modules sequestered in
large inactive complexes containing the 7SK snRNA, HEXIM1,
MePCE, LARP7, and additional factors (Barboric et al., 2009;
Jeronimo et al., 2007; Peterlin and Price, 2006; Price, 2008;
Xue et al., 2010). Several stimuli, including hypertrophic agonists
(e.g., endothelin-1), UV irradiation, HIV-1 Tat, and hexamethy-
lene bisacetamide activate P-TEFb by inducing the release of
Cdk9-cyclin T from the 7SK small nuclear ribonucleoprotein par-
ticle (snRNP) complex (Chen et al., 2008; Contreras et al., 2007;
Krueger et al., 2010; Sano et al., 2002; Sano and Schneider,
2004). These stimuli variously trigger signaling via Gq, calci-
neurin, PP1a, and PI3K, ultimately leading to remodeling of
the 7SK snRNP that promotes dissociation of Cdk9-cyclin T
and HEXIM1 away from the stable core complex of 7SK,
MePCE, and LARP7. Once activated, P-TEFb promotes tran-
scriptional elongation by phosphorylating RNA polymerase II
and associated pausing factors. Feedback autoregulation re-
sults from the rapid and potent induction ofHEXIM1 transcriptionntal Cell 27, 607–620, December 23, 2013 ª2013 Elsevier Inc. 607
Developmental Cell
Calpain 2 Targets 7SK snRNP in Megakaryopoiesis(Bartholomeeusen et al., 2012; Garriga et al., 2010; He et al.,
2006), effectively driving resequestration of Cdk9-cyclin T back
into an inactive 7SK snRNP complex (Bartholomeeusen et al.,
2012; Zhou et al., 2012).
GATA1, a master transcriptional regulator of megakaryocyte
and erythroid differentiation, physically and functionally interacts
with P-TEFb in hematopoietic cells (Bottardi et al., 2011; Elagib
et al., 2008). Somaticmutations yielding anN-terminal truncated,
‘‘short’’ GATA1 protein (GATA1s) occur in virtually all megakar-
yocytic neoplasms associated with Down syndrome (Wickrema
and Crispino, 2007). In knockin mice, the mutant GATA1s in-
duces transient megakaryocytic hyperproliferation and matura-
tional defects during fetal liver hematopoiesis (Li et al., 2005).
Megakaryocytic hyperproliferation and aberrant differentiation
have also been elicited by P-TEFb inhibition in adult mice with
megakaryocytic GATA1 deficiency, supporting the notion of
a GATA1-P-TEFb megakaryopoietic pathway that might be
affected in Down syndrome neoplasms (Elagib et al., 2008).
In the current study, we have identified a megakaryopoietic
P-TEFb activation pathway characterized by downregulation of
the 7SK snRNP core components MePCE, LARP7, and 7SK
snRNA. The protease calpain 2 critically participated in this path-
way, undergoing recruitment to P-TEFb, targeting MePCE for
proteolysis, and promoting P-TEFb-dependent megakaryocyte
morphogenesis. A cohort of coregulated cytoskeletal remodeling
factors involved in execution of the morphogenetic program was
identified in this pathway downstream of P-TEFb. In a large panel
of humanmegakaryocytic leukemias, decreased calpain 2 levels
significantly correlated with the presence of the GATA1s muta-
tion. In addition, murine fetal liver megakaryocytes from GATA1s
knockin mice displayed defects in upregulation of calpain 2 and
of downstream cytoskeletal remodeling factors. Lentiviral resto-
ration of calpain 2 expression specifically ameliorated develop-
mental defects in GATA1s knockin fetal megakaryocytes. These
findings thus support a megakaryocyte morphogenetic pathway
involving GATA1, calpain 2, P-TEFb, and the actin cytoskeleton.
Perturbations of this pathwaymay play a role in the pathogenesis
of Down syndrome megakaryocytic neoplasms.
RESULTS
Global P-TEFb Activation in Megakaryopoiesis
Previous work has suggested a critical role for high-amplitude
P-TEFb activation in megakaryocyte differentiation and diver-
gence from the erythroid lineage (Elagib et al., 2008). To examine
the mechanistic basis for this activation, 7SK snRNP complex
components were quantified in megakaryocytic, erythroid, and
undifferentiated cells derived from primary human hemato-
poietic progenitors. The principal P-TEFb factors in hematopoi-
etic cells, Cdk9 and cyclin T1, showed similar protein levels in
megakaryocytic (Mk), undifferentiated (Un), and erythroid (Ery)
cells (Figure 1A). By contrast, megakaryocytic cells specifically
downregulated all of the components of the recently defined
(Barboric et al., 2009; Xue et al., 2010) 7SK snRNP core complex:
MePCE (Me), LARP7 (L7), and the 7SK snRNA (Figures 1A and
1B). Additionally, megakaryocytic cells displayed enhanced
phosphorylation of RNA polymerase II carboxy terminal domain
serine 2 (RNAPII S2), a specific target of P-TEFb phosphorylation
(Peterlin and Price, 2006) (Figure 1C). Concomitant with downre-608 Developmental Cell 27, 607–620, December 23, 2013 ª2013 Elsgulation of the 7SK inhibitory scaffold, megakaryocytes spe-
cifically upregulated HEXIM1, reflecting increased cellular
P-TEFb activity (Bartholomeeusen et al., 2012; Garriga et al.,
2010; He et al., 2006) (Figure 1A). The megakaryocytic induction
of HEXIM1 occurred at the mRNA level (Figure S1A available
online) and was prevented by the Cdk9 inhibitor flavopiridol
(FP) and by shRNA knockdown of Cdk9 (Figure S1B). MEPCE
mRNA levels showed no significant decline during megakaryo-
cytic differentiation, suggesting regulation of this factor at the
protein level (Figure S1C).
Similar studies were carried out on a nontransformed murine
hematopoietic cell line, HPC7, which retains cytokine-respon-
sive multilineage differentiation potential (Pinto do O et al.,
1998). These cells underwent rapid and efficient erythroid or
megakaryocytic differentiation in response to 48 hr treatment
with erythropoietin (Ery) or thrombopoietin (Mk), respectively
(Figure S1D). As with primary human progenitors, HPC7 mega-
karyocytic differentiation specifically correlated with downregu-
lation of the 7SK snRNP core components and upregulation of
HEXIM1 (Figures 1D, 1E, and S1E). In addition, the HPC7 cells
did not downregulate cyclin T1 or Cdk9 during megakaryocytic
differentiation (Figure S1F). Glycerol gradient analysis of Cdk9
distribution between large, inactive and small, active complexes
(Sedore et al., 2007) revealed 80%ofmegakaryocytic Cdk9 to be
within the small complex (fraction 5). In erythroid and undifferen-
tiated cells, by contrast, the majority of Cdk9 (70%) resided in
the large complex (fraction 9) (Figure 1F). (Fraction 3 contained
insoluble debris and represents background.) Another validated
approach toward assessment of intracellular P-TEFb status con-
sists of immunoprecipitation to determine association with the
repressor HEXIM1, an interaction dependent on the integrity of
the 7SK snRNP core complex (Chen et al., 2008). This approach
confirmed a decrease in cyclin T1-HEXIM1 complexes in HPC7
cells undergoing megakaryocytic differentiation, as compared
with cells either undergoing erythroid differentiation (Figure 1G)
or maintained undifferentiated (see Figure 2C). The results in
Figure 1 thus suggest a lineage-specific mechanism of P-TEFb
activation in megakaryopoiesis, during which the dissolution of
the 7SK snRNP is accompanied by large-scale release of active
P-TEFb.
Calpain Contribution to Megakaryocytic P-TEFb
Activation and Differentiation
Mapping of the mammalian transcriptional protein interactome
has identified calpain subunits (S1 and 2) as components of an
extended 7SK snRNP network (Jeronimo et al., 2007), suggest-
ing a role for proteolysis in remodeling of this complex. To
examine the association of calpain with P-TEFb in a cell line
model of megakaryocyte differentiation, K562 cells before and
after phorbol ester (TPA) treatment underwent immunoprecipita-
tion of endogenous cyclin T1 (CT1). As described for GATA1
(Elagib et al., 2008), calpain 2 displayed inducible recruitment
to P-TEFb in association with differentiation induction (Fig-
ure 2A). By contrast, Cdk9 coprecipitated with cyclin T1 both
before and after induction. Immunoprecipitation of endogenous
HEXIM1 also revealed calpain 2 binding that was enhanced by
TPA treatment, suggesting inducible recruitment of calpain 2 to
the 7SK snRNP complex during megakaryocytic differentiation
(Figure S2A).evier Inc.
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Figure 1. Megakaryocytic Downregulation
of 7SK snRNP Core Components and Asso-
ciated P-TEFb Release
(A) Analysis of 7SK snRNP protein components.
(Left and middle panels) Primary human pro-
genitors either undifferentiated (Un) or cultured for
5 days in erythroid (Ery) or megakaryocytic (Mk)
medium underwent immunoblot for Cdk9, cyclin
T1 (CT1), HEXIM1 (H1), MePCE (Me), LARP7 (L7),
and tubulin (Tub). (Right panel) Scanning densi-
tometry from three independent experiments
conducted as in the middle panel. Results repre-
sent mean ± SEM for signals relative to those in
undifferentiated cells. In addition, all signals are
normalized to tubulin. *p < 0.05; **p < 0.01; ***p <
0.005; NS, not significant.
(B) (Left panel) Relative 7SK levels in human pro-
genitors cultured as in (A). (Right panel) Relative
7SK levels in sorted CD41GPA double-negative
and CD41+ GPA (Mk) cells from megakaryocytic
culture. Graphs represent mean ± SEM of 7SK
normalized to GAPDH in three independent
experiments.
(C) Phosphorylation of RNA polymerase II carboxyl
terminal domain serine 2 (RNAPII pS2). Human
CD34+ progenitors cultured 3 days in expansion
medium (Un) or 6 days in erythroid or megakar-
yocyte medium underwent immunoblotting of
whole-cell lysates for RNAPII pS2, total RNAPII,
or tubulin.
(D and E) HPC7 cells either undifferentiated (Un) or
grown in Ery or Mk medium underwent analysis as
in (A) and (B). Graphs both represent mean ± SEM
for three independent experiments. ***p < 0.005.
(F and G) Megakaryocytic P-TEFb release. Ex-
tracts from HPC7 cells cultured as in (D) were
subjected to glycerol gradient fractionation and
immunoblotting for Cdk9 (F) or cyclin T1
immunoprecipitation followed by immunoblot for
HEXIM1 (G). F #, fraction number.
See also Figure S1.
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Calpain 2 Targets 7SK snRNP in MegakaryopoiesisEvidence for lineage-selective, endogenous calpain activa-
tion was provided by immunoblot detection of a charac-
teristic 190 kDa filamin A cleavage fragment (Xu et al., 2010),
emerging during megakaryocytic, but not during erythroid
differentiation of primary progenitors (Figure S2B). shRNA
knockdowns confirmed that this cleavage depended on
calpain 2 expression (see Figure 3E). Calpastatin, the endoge-
nous calpain inhibitor with numerous isoforms (Takano et al.,
1993; Wendt et al., 2004), showed strong erythroid upregu-
lation of large (110 kD) and small (70 kD) variants with
minimal megakaryocytic upregulation of a large variant; by
contrast, calpain 2 showed megakaryocytic, but not erythroid,
upregulation (Figure S2C). To assess the contribution of
calpain activity to the megakaryocytic remodeling of the 7SK
snRNP (see Figure 1), calpain protease inhibitors were added
to primary megakaryocytic cultures. Notably, these inhibitors
prevented both the downregulation of MePCE and the upregu-
lation of HEXIM1 but had no effect on LARP7 (Figures 2B and
S2D). In addition, short-term administration of the inhibitors
prevented the dissociation of HEXIM1 from P-TEFb, as deter-Developmemined by coimmunoprecipitation analysis of HPC7 extracts
(Figure 2C).
Participation of calpain in megakaryocytic differentiation was
supported by the repressive effect of the inhibitors on cellular
enlargement, polyploidization, and CD41 upregulation (Figures
2D and S2E). This finding raised the possibility that the block in
MePCE downregulation associated with calpain inhibition might
occur secondary to impaired megakaryocytic differentiation. To
rule out this possibility, progenitors were allowed to undergo
megakaryocytic differentiation and were subsequently treated
for only 18 hr with calpain inhibitors. This short-course treatment
reversed MePCE downregulation in the absence of any effects
on megakaryocytic differentiation, consistent with a direct influ-
ence of calpain activity on MePCE levels (Figure S2D).
Multiple approaches were taken to confirm the contribution of
calpain to megakaryocytic differentiation. Because calpain in-
hibitors also target cathepsin proteases, progenitors underwent
control treatment with cathepsin inhibitors, which did not affect
megakaryocytic differentiation (data not shown). In addition,
we subjected progenitors to lentiviral shRNA knockdown ofntal Cell 27, 607–620, December 23, 2013 ª2013 Elsevier Inc. 609
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Figure 2. Calpain Contribution to Megakar-
yocytic P-TEFb Activation and Differen-
tiation
(A) Analysis of calpain 2 association with P-TEFb.
Extracts from K562 cells treated with either DMSO
() or 25 nM TPA (+) underwent immunoprecipi-
tation (IP) with antibody to cyclin T1 (CT1) or con-
trol immunoglobulin G followed by immunoblotting
for calpain 2 (Capn2), Cdk9 (arrow), GATA-1 (G1)
(arrow), and cyclin T1 (CT1).
(B) Effects of calpain inhibition on megakaryocytic
MePCE downregulation and HEXIM1 upregula-
tion. Primary human progenitors either undiffer-
entiated (Un) or cultured in megakaryocytic
medium (Mk) with DMSO, 40 mM calpeptin,
or 20 mM calpain inhibitor III (Capn inh III)
underwent immunoblot and densitometry as in
Figure 1A. Results from three independent
experiments are shown as mean ± SEM for
signals relative to those in undifferentiated cells.
In addition, all signals are normalized to tubulin.
*p < 0.05; **p < 0.01; ***p < 0.005; NS, not
significant.
(C) Effects of calpain inhibition on P-TEFb
dissociation from HEXIM1. Extracts from HPC7
cells grown 48 hr in expansion (Un), erythroid
(Ery), or megakaryocytic (Mk) medium under-
went immunoprecipitation for cyclin T1 (CT1),
followed by immunoblotting for HEXIM1 (H1) and
CT1. The cells undergoing megakaryocytic cul-
ture were treated in the final 16 hr with either
DMSO, 50 mM calpeptin (Calp), or 25 mM Capn
inh III (CI III).
(D) Effects of calpain inhibition on megakaryo-
cytic differentiation. Primary human progenitors
grown for 6 days in megakaryocytic medium
with DMSO or 40 mM calpeptin were analyzed
by flow cytometry for CD41 expression and
DNA content by propidium iodide staining
(PI). Cell morphology was assessed by light
microscopy of Wright-stained cytospins (200X).
Graph represents mean ± SEM for CD41 ex-
pression in three independent experiments;
*p < 0.05.
(E) Role of calpain S1 in megakaryocytic differentiation. Primary human progenitors transduced with lentiviral shRNA constructs targeting Calpain S1 (CAPNS1)
underwent megakaryocytic culture for 5 days followed by analysis as in (C). For documentation of knockdown, see Figure S2E.
See also Figure S2.
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Calpain 2 Targets 7SK snRNP in Megakaryopoiesiscalpain S1, the regulatory subunit required for calpain activity.
Two different shRNAs diminished calpain S1 levels by 3-fold
(Figure S2F), and both blocked megakaryocytic differentiation
in amanner similar to the calpain inhibitors (Figure 2E). The block
in megakaryopoiesis caused by calpain inhibition was not asso-
ciated with major impairments in viability or with redirection of
cells down the erythroid lineage (data not shown).
To further validate calpain involvement in megakaryopoiesis,
in vivo gene deletion was conducted by crossing CAPNS1f/f
(S1f/f ) mice (Tan et al., 2006) with a deleter strain expressing
Cre recombinase driven by the megakaryoctyic PF4 promoter
(Tiedt et al., 2007). Despite evidence for incomplete excision in
marrow megakaryocytic cultures (data not shown), CAPNS1f/f;
PF4-Cre (S1f/f;PF4-Cre) mice had significant thrombocytopenia
accompanied by normal red and white cell counts (Figure S2G).
In addition, CAPNS1f/f;PF4-Cre marrows showed defective
megakaryocytic maturation in ex vivo cultures, reflected by610 Developmental Cell 27, 607–620, December 23, 2013 ª2013 Elsimpairments in upregulation of CD41/CD42 and in morphogen-
esis (Figure S2H; data not shown).
Implication of Calpain 2 as the Isozyme Mediating
Megakaryopoietic P-TEFb Activation
The principal hematopoietic calpains that depend on calpain S1
for their activity consist of calpain 1 and calpain 2. To determine
which of these isozymes might participate in regulating mega-
karyopoiesis, each underwent targeting by shRNAs in primary
human progenitors, with 2-fold isozyme-specific knockdowns
obtained for both (Figure 3A). The calpain 2 knockdowns signif-
icantly impaired megakaryopoiesis, including CD41 upregula-
tion, polyploidization, and cellular enlargement, whereas calpain
1 knockdowns had no effects distinct from those of transducing
control vector (Figures 3B–3D). In addition, calpain 2, and not
calpain 1, contributed to the filamin A cleavage observed during
megakaryopoiesis (Figure 3E). shRNA knockdowns in K562evier Inc.
Figure 3. Implication of Calpain 2 as the Isoenzyme Involved in Megakaryocytic Differentiation
(A) Specificity of calpain 1 and 2 knockdowns. Primary human progenitors transduced with lentiviral shRNA constructs targeting calpain 1 (CAPN1) or 2 (CAPN2)
were analyzed by immunoblot. Arrow: calpain 2; band above arrow: lot-dependent cross-reactivity of antibody to calpain 1; smear below arrow: most likely
autolyzed calpain 2.
(B and C) Relative contributions of calpain 1 versus 2 to megakaryocytic differentiation. Progenitors transduced with lentiviral shRNA constructs as in (A) were
analyzed for megakaryocytic differentiation as in Figure 2E. Graphs represent mean ± SEM for CD41 expression or for percentage of CD41+ cells with DNA
content ofR8N, with both graphs derived from three independent experiments; **p < 0.01; ***p < 0.005; NS, not significant.
(D) Relative contributions of calpain 1 versus 2 to cellular enlargement during megakaryopoiesis. Forward scatter (FSC) profiles of cells subjected to shRNA
knockdowns and culture as in (B).
(E) Relative contributions of calpain 1 versus 2 to filamin A cleavage associated with megakaryocytic differentiation. (Left panel) Human progenitors transduced
with shRNA constructs as (A) underwent megakaryocytic culture followed by immunoblotting for filamin A (FlnA). Arrow indicates 190 kDa cleavage fragment.
(Right panel) Densitometric analysis of 190 kDa cleavage fragment from three independent experiments performed as in the left panel. Graph represents mean ±
SEM; ***p < 0.005.
(F) Relative contributions of calpain 1 versus 2 to HEXIM1 dissociation from P-TEFb. K562 cells expressing shRNAs knocking down either calpain 1 or calpain 2
underwent induction with TPA (25 nM, 48 hr) followed by immunoprecipitation of Cdk9 and immunoblotting for HEXIM1 (H1), cyclin T1 (CT1), and Cdk9.
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Figure 4. Involvement of Calpain 2 in Mega-
karyocytic Downregulation of MePCE and
Consequences of MePCE Downregulation
(A) Effects of calpain 2 knockdown on MePCE
(Me), HEXIM1 (H1), and LARP7 (L7) levels. Cells
transduced and cultured as in Figure 3B under-
went immunoblotting followed by scanning
densitometry. Graph depicts mean ± SEM for
three independent experiments. *p < 0.05; **p <
0.01; ***p < 0.005; NS, not significant.
(B) In vitro analysis of MePCE cleavage by
calpain 2. Extracts from HEK293T cells trans-
fected with FLAG-MePCE (FL-Me) expression
vector were incubated with 50 to 200 ng purified
calpain 2/S1 ± 2 mM CaCl2 (Ca
2+), followed by
immunoblot for FL-Me and GAPDH.
(C) In vitro analysis of MePCE cleavage by
calpain 2. Purified FL-Me protein from HEK293T
transfectants was subjected to in vitro cleavage
and immunoblot as in (B).
(D and E) K562 cells transduced with shRNA
constructs targeting MePCE underwent immuno-
blotting in (D). Cell morphology was assessed
by light microscopy on Wright-stained cytospins
(200X) in (E).
(F) Effect of MePCE downregulation on P-TEFb
interaction with HEXIM1. Extracts from K562 cells
subjected to shRNA knockdown of MePCE
underwent immunoprecipitation of cyclin T1 fol-
lowed by immunoblotting for HEXIM1 (H1) and
cyclin T1 (CT1).
See also Figure S3.
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1 versus calpain 2 to the dissociation of HEXIM1 from P-TEFb;
knockdown of calpain 2 notably enhanced HEXIM1 association
with P-TEFb, particularly in TPA treated cells (Figure 3F). As a
leukemic cell line, K562 cells undergo incomplete megakaryo-
cytic differentiation with TPA induction and, unlike nontrans-
formed cells, lack dynamic regulation of HEXIM1 expression.
Calpain 2 involvement in megakaryopoietic P-TEFb activation
was supported by a consistent decrease in HEXIM1 expression
associated with its knockdown (Figures 4A and S3A), but not
with calpain 1 knockdown (data not shown). In addition, MePCE
showed dramatic upregulation in cells subjected to calpain 2
knockdown (Figures 4A and S3A), suggestive of direct proteo-
lytic targeting. This notion was further supported by cell-free
assays in which recombinant calpain 2/S1 cleaved MePCE in a
calcium-dependent manner (Figures 4B and 4C). In these
assays, calpain cleavage of MePCE in cellular extracts occurred
with similar efficiency with or without RNase A addition, and
MePCE isolated in complex with cyclin T1 underwent efficient
digestion by calpain 2/S1 (Figures S3B and S3C). These findings
suggest that calpain cleavage of MePCE may occur in the con-
text of the 7SK snRNP complex. By contrast, calpain 2 knock-
down failed to reverse megakaryocytic repression of LARP7612 Developmental Cell 27, 607–620, December 23, 2013 ª2013 Elsevier Inc.(Figures 4A and S3A), as observed with
calpain inhibitors (see Figure 2B), consis-
tent with a distinct, calpain-independent
mechanism regulating this component
of the 7SK snRNP. These results thusprovide evidence for a developmental pathway in which calpain
2-dependent destruction of MePCE contributes, along with
LARP7 downregulation, to ongoing P-TEFb activation, which in
turn promotes megakaryocyte differentiation. Additional support
for this pathway came from shRNA-mediated MePCE knock-
down, which induced megakaryocyte morphogenesis in K562
cells and promoted dissociation of HEXIM1 from P-TEFb (Fig-
ures 4D–4F).
Calpain 2 and P-TEFb Regulation of Megakaryocytic
Cytoskeleton Remodeling Factors
To characterize downstream factors regulated by calpain-P-
TEFb signaling during megakaryopoiesis, in silico analysis was
applied to identify genes whose expression covaried with
HEXIM1 during megakaryocytic differentiation (see Supple-
mental Experimental Procedures). HEXIM1 was selected as
the prototype based on its documented control by P-TEFb
(Garriga et al., 2010; He et al., 2006) (see Figure S1B) and its
calpain-dependent upregulation during megakaryopoiesis (see
Figure 2B). Analysis of a data set derived from purified megakar-
yocytic progenitors at four distinct stages of development (Chen
et al., 2007) revealed a group of four actin-associated cytoskel-
eton remodeling factors whose mRNA levels paralleled that of
Figure 5. P-TEFb and Calpain 2 Regulate a
Cohort of Megakaryocytic Cytoskeletal
Remodeling Factors
(A) Expression patterns of gene cohort and
HEXIM1 during megakaryocytic differentiation.
Normalized signals obtained from the GEO data
set record GDS2521 comparing relative mRNA
levels from murine fetal liver megakaryocytic
progenitors at various developmental stages are
plotted.
(B) Assessment of P-TEFb influence on expression
of factors identified in (A). (Left panel) Primary
human progenitors transduced with shRNA con-
structs targeting Cdk9 were cultured in megakar-
yocytic medium followed by immunoblot with the
indicated antibodies. (Right panel) Densitometry
derived from three independent experiments
conducted as in the left panel showing mean ±
SEM for relative protein levels normalized to
Tubulin. *p < 0.05; **p < 0.01; ***p < 0.005; NS, not
significant. HEXIM1 (H1), a-actinin 1 (Actn1), fila-
min A (FlnA), MePCE (Me), tubulin (Tub).
(C) Assessment of calpain 2 influence on expres-
sion of factors identified in (A). Progenitors sub-
jected to calpain 2 knockdown were analyzed as
in (B). Right: densitometry derived from three in-
dependent experiments conducted as in the left
panel showing mean ± SEM for relative protein
levels normalized to Tubulin. *p < 0.05; **p < 0.01;
***p < 0.005.
See also Figure S4.
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HEXIM1, all displayed upregulation during megakaryocytic, but
not erythroid, differentiation of primary progenitors (Figures
S4A and S4B). Their regulation by P-TEFb was confirmed by
Cdk9 knockdown in primary megakaryocytic cultures. Notably,
the levels of all four factors, as well as of HEXIM1, decreased
with knockdown of Cdk9, whereas the levels of MePCE and
tubulin remained largely unaffected (Figure 5B). Cdk9 knock-
down in undifferentiated cells did affect expression of these fac-
tors but not to the same extent as in the megakaryocytic knock-
down (Figure S4C). Thus, Cdk9 likely plays a more prominent
role in megakaryocytic upregulation of these factors than in their
basal expression. Note that the relatively high Hic-5 expression
seen in undifferentiated cells subjected to lentiviral transduction
(Figure S4C), versus that in untransduced cells (Figure S4A), re-
sults from the extended culture period required for transduction
and selection. Calpain 2 regulation of these cytoskeletal remod-
eling factors in megakaryocytes was also demonstrated by
shRNA knockdowns in primary human progenitors (Figure 5C).
Two of the four factors, Mkl1 and filamin A, have been previ-
ously implicated in megakaryocyte development, including poly-Developmental Cell 27, 607–620, Dploidization (Begonja et al., 2011; Cheng
et al., 2009). One of the factors, a-actinin,
has been shown to regulate cytokinesis
both in yeast and in mammalian cells
(Mukhina et al., 2007; Wu et al., 2001).
Notably, overexpression of a-actinin con-
sistently causes a failure in cytokinesis,
leading to polyploidization. As megakar-yocytic endomitosis arises from a failure in cytokinesis (Lordier
et al., 2008), we examined the contribution of a-actinin upregula-
tion to megakaryocyte polyploidization and enlargement.
Knockdown of a-actinin 1 in primary progenitors did not affect
levels of HEXIM1 or Hic-5 but did diminish levels of filamin A,
without affecting its proteolytic cleavage (Figure 6A). a-actinin
thus does not exert feedback regulation of P-TEFb or calpain
but may interact with filamin A. Phenotypically, a-actinin 1
knockdown prevented megakaryocytic polyploidization and
enlargement but minimally affected CD41 upregulation (Figures
6B–6D and S5A; see Figures S5B–S5E for results with additional
shRNA construct). These results therefore implicate a-actinin 1
as an important target downstream of calpain-P-TEFb signaling
in megakaryocytic morphogenesis.
Calpain 2 Dysregulation in Association with the GATA1s
Mutation
In genetic complementation studies comparing effects of intro-
ducing wild-type versus mutant GATA1 alleles into GATA1-
deficient megakaryocytes, calpain 2 was previously identified
as a GATA1 target gene with a distinct pattern of regulation.ecember 23, 2013 ª2013 Elsevier Inc. 613
Figure 6. Contribution of a-Actinin-1 to
Megakaryocytic Enlargement and Poly-
ploidization
(A) Effects of megakaryocytic knockdown of
a-actinin-1 on filamin A and Hic-5 expression.
Primary human progenitors transduced with
shRNA targeting a-actinin-1 (ACTN1) were
analyzed as in Figure 5B. (Right panel) Densitom-
etry derived from three independent experiments
conducted as in the left panel showing mean ±
SEM for relative protein levels normalized to
Tubulin. *p < 0.05; **p < 0.01; NS, not significant.
HEXIM1 (H1), a-actinin 1 (Actn1), filamin A (FlnA),
tubulin (Tub).
(B–D) Effects of a-actinin-1 knockdown on mega-
karyocyte morphogenesis. Progenitors trans-
ducedwith shRNA targetinga-actinin-1 underwent
megakaryocytic culture followedbyflowcytometry
analysis as in Figures 3B–3D. Cell morphology
was assessed by light microscopy of Wright-
stained cytospins (200X). Graphs in (B) show
mean ± SEM for three independent experiments.
*p < 0.05; NS, not significant.
See also Figure S5.
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GATA1 but poor induction by GATA1s, whereas most other
GATA1 target genes studied showed equivalent regulation by
both alleles (Muntean and Crispino, 2005). These findings sug-
gested that the GATA1s mutation may interfere with calpain 2
upregulation during megakaryopoiesis. Independent support
for this notion came from our analysis of the gene expression
data set of Li et al. (2005) (GEO GDS1316), comparing fetal liver
megakaryocytes from wild-type versus GATA1s knockin mice
(G1s Ki). This data set clearly confirmed an association between
the GATA1s mutation and defective megakaryocytic upregula-
tion of calpain 2, with no abnormalities seen in calpain 1 expres-
sion (Figures 7A and S6A). Megakaryocytes deficient in overall
GATA1 expression, from the G1 Lo strain, also showedmarkedly
diminished calpain 2 expression. To assess potential conse-
quences of the calpain 2 deficiency in G1s Ki megakaryocytes,
this data set was further analyzed for expression patterns of
the calpain 2-regulated cytoskeletal remodeling factors (see Fig-
ure 5C). Notably, all four factors showed profiles nearly identical
to that of calpain 2, including defective upregulation in G1s Ki614 Developmental Cell 27, 607–620, December 23, 2013 ª2013 Elsevier Inc.and G1 Lo megakaryocytes (Figure S6B).
Thus, the calpain 2 deficiency associated
with GATA1s may impair the develop-
mental induction of key morphogenetic
mediators.
To determine whether calpain 2 defi-
ciency also correlated with the GATA1s
mutation in patient samples, we analyzed
the gene expression data set of Bourquin
et al. (2006) (GEO GSE4119) comparing
Down syndrome-associated (DS) versus
non-Down syndrome-associated (non-
DS) megakaryoblastic neoplasms. In
this data set, the GATA1s mutation
occurred in all DS cases and in none ofthe non-DS cases. Notably, the DS acute megakaryoblastic leu-
kemia (DS-AMKL) cases expressed significantly less calpain 2
than did non-DS AMKL cases (Figure 7B). Because of clinical
and molecular heterogeneity within AMKL, we also compared
twowell-defined infantile megakaryoblastic neoplasms: DS tran-
sient myeloproliferative disorder (DS-TMD) versus AMKL with
the t(1;22) chromosomal abnormality. Again, significantly less
calpain 2 expression occurred in the DS samples (Figure S6C),
confirming a clinical correlation between the GATA1s mutation
and calpain 2 deficiency. TP53BP2, a control gene neighboring
calpain 2 on chromosome 1, showed no differences in expres-
sion between the DS-TMD versus t(1;22) cases (data not shown).
Contribution of Calpain 2 Deficiency to GATA1s-
Associated Dysmegakaryopoiesis
The GATA1s mutation causes abnormalities in fetal liver mega-
karyopoiesis, including excessive cellular proliferation and im-
paired upregulation of several differentiation markers (Li et al.,
2005). Consistent with these prior findings, we observed defects
in CD42 upregulation, polyploidization, and cellular enlargement
Developmental Cell
Calpain 2 Targets 7SK snRNP in Megakaryopoiesisin G1s Ki fetal liver megakaryocytes (Figures 7C and 7D,
comparewild-type [WT] vector versusG1sKi vector; FigureS6E).
Immunoblot analysis confirmed diminished calpain 2 protein
expression in G1s Ki megakaryocytes, with no alteration in cal-
pastatin levels (Figure S6D). Consistent with its regulation of
P-TEFb activity, calpain 2 deficiency in G1s Ki megakaryocytes
correlated with global deficiency in phosphorylation on serine 2
within the carboxy terminal domain of RNA polymerase II (Fig-
ure S6D). To determine whether calpain 2 deficiency contributes
to GATA1s-associated dysmegakaryopoiesis, fetal liver cells
transduced with control or calpain 2-expressing lentivirus under-
went megakaryocytic culture and analysis. Transduction of
G1s Ki cells with calpain 2-expressing lentivirus significantly
enhanced several differentiation parameters within the CD41+
megakaryocytic population: CD42 expression, polyploidization,
proliferation arrest reflected by PKH26 dye retention, and cellular
enlargement (Figures 7C and 7D). By comparison, nontrans-
duced (GFP) megakaryocytic cells derived from control vector
versus calpain 2 lentiviral exposures showed no differences in
these parameters (data not shown). Wild-type fetal liver mega-
karyocytes transduced with calpain 2 lentivirus also showed
increases in CD42 expression, cellular enlargement, and poly-
ploidization (see Figures 7C and 7D). However, the impact of
enforcing calpain 2 expression inwild-type cells was significantly
less than in G1s Ki cells (see graphs in Figures 7C and 7D). With
regard to proliferation, enforced calpain 2 had no significant
effect in wild-type cells, in contrast to its arresting effect in G1s
Ki cells (Figure 7C). A protease-deficient calpain 2 mutant
(C105S) completely failed to rescue cellular enlargement in
G1s Ki fetal liver progenitors and relatively weakly augmented
CD42 levels, the latter effect possibly due to calpastatin seques-
tration (Figures S6F and S6G). To determine whether MePCE
downregulation might contribute to the rescue conferred by en-
forced calpain 2 expression, G1s Ki fetal liver cells underwent
shRNA-mediated MePCE knockdown, which enhanced cellular
enlargement and CD42 expression (Figure 7F). In aggregate,
these results support calpain 2 deficiency and consequent fail-
ure of MePCE downregulation as factors contributing to the
defective fetal megakaryopoiesis associated with the GATA1s
mutation (see pathway diagram in Figure 8).
DISCUSSION
The hypertrophic response in cardiomyocytes is driven by
P-TEFb activation through a mechanism involving dissociation
of Cdk9-Cyclin T complexes from the 7SK snRNP (Sano et al.,
2002). How hypertrophic signaling induces this dissociation re-
mains unclear but may involve a conformational shift in the
7SK snRNP complex elicited by the phosphatase activity of cal-
cineurin (Chen et al., 2008). Recent studies have revealed a
contribution of calpain activity to cardiomyocyte hypertrophy in
diabetic mice, and calpain activation also maintains cardiomyo-
cyte integrity during hemodynamic stress (Li et al., 2011; Taneike
et al., 2011). This latter function appears to occur through a
membrane repair mechanism but may also involve coordinated
programming of cytoskeletal remodeling (Yamaguchi et al.,
2012).
In megakaryopoiesis, the morphogenetic program appears to
be initiated by calpain 2-mediated proteolysis of MePCE, a crit-Developmeical 7SK snRNP core component known to stabilize the 7SK
snRNA (Barboric et al., 2009; Xue et al., 2010). Megakaryocytic
calpain activation correlates with upregulation of calpain 2 but
must also involve specialized signaling via calcium influx, upon
which calpain function is absolutely dependent (Campbell and
Davies, 2012). An additional contribution to differential calpain
activation in megakaryocytic versus erythroid cells likely resides
in the erythroid-specific upregulation of calpastatin, that is, the
calpain inhibitor (Figure S2C). During megakaryopoiesis, cal-
pain-induced downregulation of the 7SK snRNA, a required
cofactor for HEXIM repression of Cdk9 (Michels et al., 2004;
Yik et al., 2003), uncouples P-TEFb from repressive feedback
mediated by continually rising HEXIM1 levels. In addition to cal-
pain-dependent downregulation of MePCE, a distinct mecha-
nism involving calpain-independent downregulation of LARP7,
another 7SK snRNP core component, probably contributes as
well to megakaryocytic downregulation of 7SK snRNA. Mecha-
nisms for LARP7 downregulation could potentially involve
alternative proteolytic pathways as well as transcriptional and
posttranscriptional repression. Thus, multiple pathways during
megakaryopoiesis likely cooperate in promoting global and irre-
versible shifting of P-TEFb toward its active form, thereby driving
progression along a developmental pathway of continual cellular
enlargement (see Figure 8). Whether megakaryocytic P-TEFb
activation reinforces the very pathways that promote its activa-
tion is an intriguing topic for future investigation.
Normal megakaryopoiesis comprises, among many changes,
the coordinated upregulation of cytoskeletal regulatory proteins
that promote the dramatic cellular enlargement. Comparisons of
transcriptional profiles from discrete developmental stages of
megakaryopoiesis show activation of cytoskeletal-associated
genes to occur early, concomitant with activation of genes in
the m-calpain (calpain 2) pathway (Chen et al., 2007). Similarly,
analysis of genes upregulated during polyploidization has identi-
fied a large cohort of cytoskeletal factors, including ACTN1 (en-
coding a-actinin-1) (Raslova et al., 2007). Factors previously
known to contribute to megakaryocytic cytoskeletal remodeling
include SRF and Mkl1 (also known as MAL or MRTF-A), which
together transactivate genes contributing to actin stress-fiber
formation (Gilles et al., 2009; Halene et al., 2010).
In the current study, four cytoskeletal regulatory factors were
found to be controlled by the calpain 2-P-TEFb signaling
pathway. One of these factors, Mkl1, itself regulates expression
of cytoskeletal genes duringmegakaryopoiesis. Three of the fac-
tors, a-actinin, Hic-5, and Mkl1, have been implicated in cardio-
myocyte hypertrophy (Kuwahara et al., 2010; Ridinger et al.,
2009; Yund et al., 2009). Two of the factors, a-actinin and filamin
A, function in actin crosslinkage, leading to F-actin stabilization
(Mukhina et al., 2007; Nakamura et al., 2011), and our data
suggest that a-actinin may regulate filamin A levels in megakar-
yocytes (Figure 6A). An interesting property shared by Mkl1,
Hic-5, and filamin A consists of their dual functions as actin-bind-
ing factors in the cytosol and transcriptional regulators in the
nucleus (Gilles et al., 2009; Heitzer and DeFranco, 2006; Naka-
mura et al., 2011), potentially allowing for cytoskeletal-nuclear
crosstalk during megakaryopoiesis. Studies of megakaryopoie-
sis in knockout mice have demonstrated participation of both
Mkl1 and filamin A in polyploidization (Begonja et al., 2011;
Cheng et al., 2009). Our knockdown experiments in primaryntal Cell 27, 607–620, December 23, 2013 ª2013 Elsevier Inc. 615
Figure 7. Calpain 2 Deficiency Occurs in Megakaryocytic Cells with Mutant GATA1s and Contributes to Aberrant Megakaryopoiesis
(A) Expression patterns of calpain 2 (CAPN2) in developing fetal liver megakaryocytes fromwild-type (WT), GATA1s knockin (G1s Ki), andmegakaryocytic GATA1
knockout (G1 Lo) mice. Normalized signals obtained from the GEO data set record GDS1316 comparing relative mRNA levels from murine fetal liver pre-
megakaryocytes (pre-Mk) and megakaryocytes (Mk) of the indicated strains are plotted. Paired bars represent two independent experiments.
(B) Calpain 2 expression in human megakaryocytic proliferative disorders bearing the GATA1s mutation. Normalized signals obtained from the GEO data set
record GSE4119 comparing relative mRNA levels from cases of acute megakaryoblastic leukemia occurring in patients with Down syndrome (DS-AMKL) versus
cases unassociated with Down syndrome (non-DS-AMKL) are plotted.
(C and D) Effects of lentiviral-mediated calpain 2 restoration on megakaryocytic differentiation in fetal liver progenitors with GATA1s mutation. Day 13.5 fetal
liver progenitors from G1s Ki and wild-type (WT) mice underwent transduction with calpain 2 or control lentiviral expression constructs, followed by megakar-
yocytic culture and flow cytometric analysis. GFP+-transduced cells were analyzed for expression of CD42, ploidy (PI), megakaryocytic growth arrest (PKH26
retention in CD41+ cells), and megakaryocytic cell size (FSC in CD41+ cells). Each of the four graphs in (C) and (D) represent mean ± SEM for three independent
experiments. Graphic results are presented as fold change relative to vector-transduced cells within each strain; *p < 0.05; **p < 0.01; ***p < 0.005; NS, not
significant.
(legend continued on next page)
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Figure 8. AModel Depicting the Pathway for
P-TEFb Activation in Megakaryopoiesis and
Perturbation of This Pathway by a Leukemo-
genic GATA1 Mutation
In the top panel, nonmegakaryocytic cells, such as
erythroblasts, show reversible, feedback-regu-
lated P-TEFb activation in which P-TEFb and
HEXIM1 reversibly associate with the 7SK snRNP.
In this scenario, the majority of P-TEFb resides
within the large inactive complex.
In the middle panel, megakaryocytes show global
and irreversible P-TEFb activation. In this scenario,
calpain 2 undergoes upregulation and activation,
promoting 7SK snRNP destruction through direct
proteolysis of MePCE. An additional contribution
derives from calpain-independent LARP7 down-
regulation. In the absence of the 7SK snRNP,
chronic unopposed P-TEFb activation drives
transcription of a cohort of genes that includes
cytoskeletal remodeling factors that promote
megakaryocyte morphogenesis and HEXIM1.
In the bottom panel, megakaryocytic upregulation
of calpain 2 is impaired in cells bearing the leuke-
mogenic GATA1s mutation. These cells show
impairment in the destruction of the 7SK snRNP,
retain capacity for feedback inhibition of P-TEFb,
and are compromised in the activation of key
P-TEFb target genes.
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whose upregulation contributes to megakaryocytic polyploidiza-
tion and enlargement (Figures 6B–6D; Figures S5C–S5E). Future
experiments will address whether Hic-5 contributes to megakar-
yocyte morphogenesis and the extent to which these cytoskel-
etal factors engage in crosstalk.
The leukemia-associated GATA1 mutant, GATA1s, causes
developmental abnormalities, including hyperproliferation in
fetal liver megakaryocytic progenitors (Li et al., 2005). The tran-
scriptional defects in GATA1s responsible for these abnormal-
ities have been attributed to a loss of repressive control over
oncogenic factors such as c-Myc, c-Myb, PU.1, Ikaros, and
GATA-2 and an array of E2F target genes (Klusmann et al.,
2010; Li et al., 2005). The defects in GATA1s function may arise
from loss of a binding domain for pRb and E2F (Kadri et al., 2009;
Klusmann et al., 2010). Our data suggest that loss of an activa-
tion function, namely, upregulation of calpain 2, also represents
a critical defect in GATA1s. Previous data showGATA1s to retain
normal activation capability for most megakaryocytic target(E) Impact of MePCE knockdown on megakaryocyte differentiation in G1S Ki fetal liver cells. Embryonic day
shRNA constructs, selected in puromycin, subjected to Mk culture, and analyzed for size (FSC) and CD42 upr
MePCE in MEL cells transduced with the shRNA to MEPCE (A5).
See also Figure S6.
Developmental Cell 27, 607–620, Dgenes examined, with the exception of
calpain 2 and GP1ba (Muntean and
Crispino, 2005). The ability of enforced
calpain 2 expression to induce CD42
upregulation in G1s Ki fetal liver megakar-
yocytes (Figure 7C) suggests that GP1ba
may lie downstream of calpain 2 in
GATA1 regulation of megakaryopoiesis.The likelihood that defective signaling via calpain 2 to P-TEFb
contributes to DS megakaryocytic neoplasia is supported by
the deficiency of calpain 2 expression in DS-AMKL/TMD speci-
mens and by studies in which P-TEFb inhibition in mice elicits
a megakaryoblastic disorder resembling DS-TMD (Elagib et al.,
2008). Future studies will examine the interplay of pRb-E2F,
Calpain 2-P-TEFb, and other hypertrophic pathways in normal
and neoplastic megakaryopoiesis.EXPERIMENTAL PROCEDURES
Cell Culture
Purified primary human CD34+ hematopoietic progenitors were cultured in
serum-free unilineage media as described previously (Elagib et al., 2008).
Undifferentiated cells (Un) were cultured in prestimulation medium for 72 hr.
Erythroid (Ery) and megakaryocytic (Mk) cells were cultured in their respective
media for the indicated durations following an initial prestimulation phase.
Protease inhibitors (EMD Chemicals) dissolved in DMSO or DMSO only were
added to cultures as indicated. K562 and HEK293T cells were cultured under
standard conditions (Elagib et al., 2008). HPC7 cells weremaintained in growth13.5 fetal liver cells were transduced with lentiviral
egulation. Immunoblot on left shows knockdown of
ecember 23, 2013 ª2013 Elsevier Inc. 617
Developmental Cell
Calpain 2 Targets 7SK snRNP in Megakaryopoiesismedium (IMDM, 5% FBS, 100 ng/ml SCF) as described previously (Pinto do O
et al., 1998); for differentiation induction, the cells were cultured 48 hr in either
megakaryocyte medium (IMDM, 5% FBS, 2.5 ng/ml SCF, 50 ng/ml TPO,
10 ng/ml IL-6) or erythroid medium (IMDM, 5% FBS, 20 ng/ml SCF, 4 U/ml
EPO). Fetal liver cells from day 13.5 mouse embryos were dissaggregated,
depleted of red cells, and then expanded in a 1:1 mixtue of RPMI 1640 and
Dulbecco’s modified Eagle’s medium supplemented with 100 ng/ml SCF,
20 ng/ml IL-3, 2 U/ml erythropoietin, and 1% Nutridoma (Roche). To promote
megakaryopoiesis, the cells were transferred to RPMI 1640 with 10% fetal
bovine serum, 25 ng/ml SCF, and 10 ng/ml TPO. To prevent shedding of the
CD42 antigen (Nishikii et al., 2008), the medium was supplemented after the
initial 24 hr with 20 mM GM6001 (EMD Chemicals). Megakaryocytic cultures
derived from marrow of 5-FU-treated mice were performed as described by
Hamlett et al. (2008).
Cell Transduction and Transfection
For lentiviral shRNA-mediated knockdown, pLKO.1-derived constructs target-
ing humanmRNAs of interest were purchased fromOpen Biosystems. For len-
tiviral expression of calpain 2, a full-length rat cDNA was inserted upstream of
an IRES element previously introduced into pWPXLD, a parent vector provided
by Didier Trono (E´cole Polytechnique Fe´de´ral de Lausanne). Construct pack-
aging by HEK293T cotransfection with pCMV-dR8.74 plus pMD2.G was fol-
lowed by spinoculation of target cells (Elagib et al., 2008). Cells transduced
with shRNA constructs underwent selection with puromycin, 2 mg/ml during
an initial 72 hr expansion phase and 1 mg/ml during the subsequent differenti-
ation phase. FLAG-MePCE plasmid was a gift from Dr. Matjaz Barboric
(University of Helsinki) (Barboric et al., 2009).
Immunoprecipitation, Immunoblot, and RNA Quantitation
Immunoprecipitation of endogenous P-TEFb and HEXIM1 from HPC7 and
K562 cellular extracts, followed by immunoblot detection, was performed as
described (Elagib et al., 2008). For direct immunoblot analysis of cells,
whole-cell lysates in 1X SDS-PAGE loading buffer supplemented with prote-
ase and phosphatase inhibitors underwent shearing of DNA prior to standard
analysis (Elagib et al., 2008). Densitometry data were acquired on a GS800
calibrated densitometer (Bio-Rad) and analyzed with Quantity One software
(Bio-Rad). For quantitation of HEXIM1, MEPCE, and 7SK, total cellular RNA
isolated using the RNeasy Plus Mini Kit (QIAGEN) underwent conversion to
cDNA using the iScript kit (Bio-Rad Life Science) followed by quantitative
PCR on the iCycler platform using iQ SYBR Green Supermix (Bio-Rad). Rela-
tive transcript levels were calculated using GAPDH normalization with the
DDCT formula.
Glycerol Gradient Analysis
HPC7 extracts (in 150 mM NaCl, 2 mM MgCl2, 10 mM HEPES, 1 mM DTT,
1 mM PMSF, 20 mM calpain inhibitor III, EDTA-free protease inhibitor cocktail
[Roche], 40 U/ml RNase inhibitor [Promega], and 0.5%NP-40) were loaded on
10%–45%glycerol gradients prepared in extraction buffer. The gradients were
spun in a SW-41 rotor at 40,000 g for 16 hr at 4C, and resultant fractions
underwent SDS-PAGE-immunoblot.
In Vitro MePCE Cleavage Assays
FLAG-MePCE purified from HEK293T transfectants, or unpurified extracts,
underwent incubation in a 30 ml reaction volume with 50–200 ng His6-Calpain
2/S1 complex purified from Escherichia coli (EMD Chemicals). Where indi-
cated, CaCl2 was added to a final concentration of 2 mM. After incubation at
30C for 15 min, the reaction was stopped by addition of an equal volume of
2X SDS-PAGE loading buffer with 100 mM calpain inhibitor III, followed by
immunoblot analysis with anti-FLAG and anti-MePCE antibodies.
Flow Cytometry and Cell Sorting
CD41 and GPA in human progenitors, CD41 in murine progenitors, and ploidy
in both species were assessed as described (Elagib et al., 2008). For antibody
detection of murine CD42b, cells were stained with phycoerythrin-conjugated
anti-GPIba (Emfret Analytics). Dye dilution analysis of proliferation was per-
formed on fetal liver cells after spinoculation and involved washing of cells fol-
lowed by incubation with the red membrane dye PKH26 (Sigma-Aldrich). After
stopping the staining reaction with 1%BSA, cells underwent washing followed618 Developmental Cell 27, 607–620, December 23, 2013 ª2013 Elsby culture for 72 hr in megakaryocytic medium. Proliferation of transduced
megakaryocyteswas analyzed by gating onGFP+CD41+ cells. For cell sorting,
progenitors costained for CD41 andGPAwere fractionated on a FACSVantage
SE. Turbo Sorter with DIVA Option (Becton Dickinson).
Mice
Mice with megakaryocytic deletion of Calpain S1 were derived from the
capn4PZ strain (Tan et al., 2006). The PF4-Cre transgenic strain was purchased
as C57BL/6-Tg(Pf4-cre)Q3Rsko/J (The Jackson Laboratory). The G1S Ki mice
consisted of the GATA1DE2 strain (Li et al., 2005). Blood obtained by retro-
orbital phlebotomy was analyzed for complete blood count values (CBC) on
a Hemavet 950FS analyzer (Drew Scientific).
Statistical Analysis
Statistical comparisons between two groups employed Student’s t test (two-
tailed, unpaired), and comparisons among >2 groups employed ANOVA.
SUPPLEMENTAL INFORMATION
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